FeesSafety
Pluang+

Allogene Therapeutics to present at major investor conferences in Nov-Dec 2026

Market News
26 Oct 2026, 15:30 WIB
GlobeNewsWire
View Source
Neutral
Allogene Therapeutics to present at major investor conferences in Nov-Dec 2026

Allogene Therapeutics, a biotech company developing allogeneic CAR T therapies for cancer and autoimmune diseases, announced its participation in three upcoming investor conferences in November and December 2026. These events include the UBS Global Biopharma Conference, Jefferies Global Healthcare Conference, and Piper Sandler Healthcare Conference. The company will provide live webcasts and replays on its website, offering investors updates on its progress and pipeline. This engagement highlights Allogene's efforts to keep investors informed as it advances its off-the-shelf CAR T cell therapy products.

Allogene Therapeutics' upcoming investor conferences provide context for readers interested in biotech developments. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 26, 2026 19:02 WIB: Of 150 priced health-sector US stocks tradable on Pluang, 78 rose and 48 fell today. Notable movers include VTRS at USD 18.44 (+2.44%), WGS at USD 57.50 (+2.40%), and NVS at USD 153.99 (+1.90%).

More News

A Race Against Blindness relaunches holiday fundraiser with $125K family prize package including Toyota Sienna and Disney vacation

A Race Against Blindness relaunches holiday fundraiser with $125K family prize package including Toyota Sienna and Disney vacation

A Race Against Blindness has brought back its popular Miles, Magic & Mochas holiday fundraiser, offering supporters a chance to win a prize package valued at $125,000. The package includes a 2026 Toyota Sienna Platinum, a $20,000 Disney vacation awar...

Neutral
51 minutes ago
Shell buys back over 2 million shares as part of its ongoing repurchase program.

Shell buys back over 2 million shares as part of its ongoing repurchase program.

On November 18, 2026, Shell plc repurchased a total of approximately 2.15 million shares across multiple trading venues including the London Stock Exchange and European markets. These shares are being bought back for cancellation under Shell's existi...

Company Fundamentals
Neutral
57 minutes ago
MercadoLibre and Amazon show strong long-term growth despite short-term profit challenges.

MercadoLibre and Amazon show strong long-term growth despite short-term profit challenges.

MercadoLibre and Amazon have both delivered impressive returns over the past decade by continuously growing their customer base, revenue, and profits. MercadoLibre is deliberately sacrificing short-term profits to invest in long-term growth, expandin...

Market News
Bullish
1 hour ago
Pfizer set to pay its 352nd consecutive dividend on Dec 7, 2026, despite potential challenges ahead.

Pfizer set to pay its 352nd consecutive dividend on Dec 7, 2026, despite potential challenges ahead.

Pfizer will pay its 352nd consecutive quarterly dividend on December 7, 2026, maintaining a strong track record for investors. The company faces challenges like a patent cliff, costly acquisitions, and clinical setbacks that could threaten this strea...

Company Fundamentals
Neutral
1 hour ago
General Mills and Realty Income offer high dividend yields as their stock prices near 52-week lows.

General Mills and Realty Income offer high dividend yields as their stock prices near 52-week lows.

General Mills and Realty Income are trading near their 52-week lows, presenting attractive dividend yields of about 7% and 5.7% respectively. General Mills has a strong dividend history of 127 years and covers its dividend with free cash flow despite...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App